Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Status

Withdrawn

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00406172

Enrollment

Registered

2006-12-04

Start date

2006-11-30

Completion date

2006-11-30

Last updated

2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystoid Macular Edema

Brief summary

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.

Interventions

DRUGBevacizumab

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Pseudophakic eyes with macular edema

Exclusion criteria

* Other retinopathies

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026